Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro
/in Acute Leukemia, International Publications[Local hyperthermia of malignant brain tumors]
/in Glioblastoma, Hyperthermia, International PublicationsA preliminary investigation of the parallelogram concept in genetic monitoring and risk estimation
/in International Publications, Newcastle Disease VirusImmunological enhancement by fat-soluble vitamins, minerals, and trace metals: a factor in cancer prevention
/in International Publications, MicronutrientsA proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia
/in Acute Leukemia, International PublicationsDoxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma
/in Hyperthermia, International Publications, Soft Tissue Sarcoma[Effect of whole-body artificial hyperthermia on the immunity function in cancer patients]
/in Gastric Cancer, Hyperthermia, International PublicationsCombination radiofrequency hyperthermia and chemotherapy (BCNU) for brain malignancy. Animal experience and two case reports
/in Glioblastoma, Hyperthermia, International Publications[Local hyperthermia therapy of malignant brain tumor using radiofrequency. Effects on subcutaneously transplanted experimental brain tumor]
/in Glioblastoma, Hyperthermia, International PublicationsIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer